Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2003 1
2009 1
2011 1
2012 1
2013 1
2014 1
2015 3
2016 1
2017 1
2018 2
2019 1
2020 4
2021 2
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Metaplastic carcinoma of the breast.
McKinnon E, Xiao P. McKinnon E, et al. Arch Pathol Lab Med. 2015 Jun;139(6):819-22. doi: 10.5858/arpa.2013-0358-RS. Arch Pathol Lab Med. 2015. PMID: 26030252 Free article. Review.
It shares many similarities with invasive ductal carcinoma and benign lesions on mammography, which further complicates the diagnosis. Treatment for metaplastic breast carcinoma is relatively unknown because of the rarity of the disease, but studies suggest t …
It shares many similarities with invasive ductal carcinoma and benign lesions on mammography, which further complicates the diagnosis. Treat …
Metaplastic breast carcinoma: case series and review of the literature.
Esbah O, Turkoz FP, Turker I, Durnali A, Ekinci AS, Bal O, Sonmez OU, Budakoglu B, Arslan UY, Oksuzoglu B. Esbah O, et al. Asian Pac J Cancer Prev. 2012;13(9):4645-9. doi: 10.7314/apjcp.2012.13.9.4645. Asian Pac J Cancer Prev. 2012. PMID: 23167395 Free article. Review.
Metaplastic breast carcinoma (MpBC) is a rare disease entity, accounting for less than 1% of all breast carcinomas. ...
Metaplastic breast carcinoma (MpBC) is a rare disease entity, accounting for less than 1% of all breast carcinomas. ...
Metaplastic breast carcinoma: a case report and systematic review of the literature.
Toumi Z, Bullen C, Tang AC, Dalal N, Ellenbogen S. Toumi Z, et al. Pathol Int. 2011 Oct;61(10):582-8. doi: 10.1111/j.1440-1827.2011.02698.x. Epub 2011 Jul 25. Pathol Int. 2011. PMID: 21951667 Review.
A 78-year-old retired woman was diagnosed with metaplastic breast carcinoma (MBC), a rare tumor, in our hospital. We reviewed 15 articles with a total of 1328 patients to determine the epidemiology, clinical features, biomarkers, histology, management …
A 78-year-old retired woman was diagnosed with metaplastic breast carcinoma (MBC), a rare tumor, in our hospital. We re …
Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment.
Aydiner A, Sen F, Tambas M, Ciftci R, Eralp Y, Saip P, Karanlik H, Fayda M, Kucucuk S, Onder S, Yavuz E, Muslumanoglu M, Igci A. Aydiner A, et al. Medicine (Baltimore). 2015 Dec;94(52):e2341. doi: 10.1097/MD.0000000000002341. Medicine (Baltimore). 2015. PMID: 26717372 Free PMC article.
Metaplastic breast carcinoma (MBC) differs from classic invasive ductal carcinomas regarding incidence, pathogenesis, and prognosis. ...After correctly matching the patients with 1 of the 2 groups, they were compared to determine differences in response to tr …
Metaplastic breast carcinoma (MBC) differs from classic invasive ductal carcinomas regarding incidence, pathogenesis, a …
Clinical features of metaplastic breast carcinoma: A single-center experience.
Ertas G, Başal FB, Üçer AR, Benzer E, Altundağ MB, Demirci U, Çetin B, Karatas F. Ertas G, et al. J Cancer Res Ther. 2020 Oct-Dec;16(6):1229-1234. doi: 10.4103/jcrt.JCRT_964_19. J Cancer Res Ther. 2020. PMID: 33342778 Free article. Clinical Trial.
AIM: Metaplastic breast cancer (MBC) is a rare subtype with unusual clinical features. We aimed to analyze treatment results and define patients' characteristic features in our large MBC patient series. ...
AIM: Metaplastic breast cancer (MBC) is a rare subtype with unusual clinical features. We aimed to analyze treatment results and defi …
The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma.
Wu SG, Yang SP, Zhang WW, Wang J, Lian CL, Chen YX, He ZY. Wu SG, et al. Sci Rep. 2020 Dec 16;10(1):22070. doi: 10.1038/s41598-020-79166-5. Sci Rep. 2020. PMID: 33328559 Free PMC article. Clinical Trial.
The management of metaplastic breast carcinoma (MBC) has largely paralleled the paradigms used for invasive ductal carcinoma (IDC) in the current National Comprehensive Cancer Network guidelines of breast cancer. ...
The management of metaplastic breast carcinoma (MBC) has largely paralleled the paradigms used for invasive ductal carc …
Metaplastic carcinoma of the breast with mesenchymal differentiation (carcinosarcoma). A unique presentation of an aggressive malignancy and literature review.
Salemis NS. Salemis NS. Breast Dis. 2018;37(3):169-175. doi: 10.3233/BD-170313. Breast Dis. 2018. PMID: 29504519 Review.
Metaplastic carcinoma of the breast with mesenchymal differentiation (MCMD), previously known as carcinosarcoma, is a very rare and aggressive tumor that has been recently classified as a subtype of metaplastic breast carcinoma. It accounts for 0.08%-0.2% of …
Metaplastic carcinoma of the breast with mesenchymal differentiation (MCMD), previously known as carcinosarcoma, is a very rare and aggressi …
TROP2, androgen receptor, and PD-L1 status in histological subtypes of high-grade metaplastic breast carcinomas.
Chartier S, Brochard C, Martinat C, Coussy F, Feron JG, Kirova Y, Cottu P, Marchiò C, Vincent-Salomon A. Chartier S, et al. Histopathology. 2023 Apr;82(5):664-671. doi: 10.1111/his.14852. Epub 2023 Jan 9. Histopathology. 2023. PMID: 36527253 Free article.
AIMS: High-grade metaplastic breast carcinoma (HG-MBC) is a rare subtype of invasive breast carcinoma, mostly triple-negative. ...Lastly, 21 (32.3%) cases were HER2-low, all being HER2 1+, with no HER2 2+. CONCLUSION: Metaplastic breast carci …
AIMS: High-grade metaplastic breast carcinoma (HG-MBC) is a rare subtype of invasive breast carcinoma, mostly triple-ne …
In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types.
Matossian MD, Chang T, Wright MK, Burks HE, Elliott S, Sabol RA, Wathieu H, Windsor GO, Alzoubi MS, King CT, Bursavich JB, Ham AM, Savoie JJ, Nguyen K, Baddoo M, Flemington E, Sirenko O, Cromwell EF, Hebert KL, Lau F, Izadpanah R, Brown H, Sinha S, Zabaleta J, Riker AI, Moroz K, Miele L, Zea AH, Ochoa A, Bunnell BA, Collins-Burow BM, Martin EC, Burow ME. Matossian MD, et al. Clin Transl Oncol. 2022 Jan;24(1):127-144. doi: 10.1007/s12094-021-02677-8. Epub 2021 Aug 9. Clin Transl Oncol. 2022. PMID: 34370182 Free PMC article.
Metaplastic breast carcinoma (MBC) is a rare breast cancer subtype with rapid growth, high rates of metastasis, recurrence and drug resistance, and diverse molecular and histological heterogeneity. ...
Metaplastic breast carcinoma (MBC) is a rare breast cancer subtype with rapid growth, high rates of metastasis, recurre …
Best Practice (Efficient) Immunohistologic Panel for Diagnosing Metaplastic Breast Carcinoma.
Han M, Zhang H, Dabbs DJ. Han M, et al. Appl Immunohistochem Mol Morphol. 2021 Apr 1;29(4):265-269. doi: 10.1097/PAI.0000000000000873. Appl Immunohistochem Mol Morphol. 2021. PMID: 32858538
GATA 3 was positive in 63% MBCs, and nonspecific staining for vimentin and smooth muscle actin were common. Random combination of up to 3 antibodies against keratins including p63 showed sensitivities ranging from 80.9% to 97.9%. ...
GATA 3 was positive in 63% MBCs, and nonspecific staining for vimentin and smooth muscle actin were common. Random combination of up …
25 results